Literature DB >> 12570764

The ATP-binding site of type II topoisomerases as a target for antibacterial drugs.

Anthony Maxwell1, David M Lawson.   

Abstract

DNA topoisomerases are essential enzymes in all cell types and have been found to be valuable drug targets both for antibacterial and anti-cancer chemotherapy. Type II topoisomerases possess a binding site for ATP, which can be exploited as a target for chemo-therapeutic agents. High-resolution structures of protein fragments containing this site complexed with antibiotics or an ATP analogue have provided vital information for the understanding of the action of existing drugs and for the potential development of novel anti-bacterial agents. In this article we have reviewed the structure and function of the ATPase domain of DNA gyrase (bacterial topoisomerase II), particularly highlighting novel information that has been revealed by structural studies. We discuss the efficacy and mode of action of existing drugs and consider the prospects for the development of novel agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570764     DOI: 10.2174/1568026033452500

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  61 in total

1.  Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.

Authors:  Steven Bellon; Jonathan D Parsons; Yunyi Wei; Koto Hayakawa; Lora L Swenson; Paul S Charifson; Judith A Lippke; Robert Aldape; Christian H Gross
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 2.  Structural and functional dissection of aminocoumarin antibiotic biosynthesis: a review.

Authors:  David M Lawson; Clare E M Stevenson
Journal:  J Struct Funct Genomics       Date:  2012-05-27

3.  Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.

Authors:  Trudy H Grossman; Douglas J Bartels; Steve Mullin; Christian H Gross; Jonathan D Parsons; Yusheng Liao; Anne-Laure Grillot; Dean Stamos; Eric R Olson; Paul S Charifson; Nagraj Mani
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  Crystallization and X-ray diffraction data collection of topoisomerase IV ParE subunit from Xanthomonas oryzae pv. oryzae.

Authors:  Hye Jeong Shin; Mirim Yun; Ju Yeon Song; Hyun Jeong Kim; Yong Seok Heo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-05-22

5.  Crystallization and preliminary X-ray analysis of the O-carbamoyltransferase NovN from the novobiocin-biosynthetic cluster of Streptomyces spheroides.

Authors:  Inmaculada Gómez García; Caren L Freel Meyers; Christopher T Walsh; David M Lawson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-25

6.  Modulation of S. aureus and P. aeruginosa biofilm: an in vitro study with new coumarin derivatives.

Authors:  Tapas Das; Manash C Das; Antu Das; Sukhen Bhowmik; Padmani Sandhu; Yusuf Akhter; Surajit Bhattacharjee; Utpal Ch De
Journal:  World J Microbiol Biotechnol       Date:  2018-11-08       Impact factor: 3.312

7.  Crystallization and preliminary X-ray crystallographic analysis of DNA gyrase GyrB subunit from Xanthomonas oryzae pv. oryzae.

Authors:  Ha Yun Jung; Ki Jeung Lee; Kyung Ha Kim; Ji Hye Hyoung; Mi Ra Han; Hyun Kyoung Kim; Lin-Woo Kang; Yeh-Jin Ahn; Yong-Seok Heo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-12-25

8.  Optimizing glycosyltransferase specificity via "hot spot" saturation mutagenesis presents a catalyst for novobiocin glycorandomization.

Authors:  Gavin J Williams; Randal D Goff; Changsheng Zhang; Jon S Thorson
Journal:  Chem Biol       Date:  2008-04

9.  Five gene products are required for assembly of the central pyrrole moiety of coumermycin A1.

Authors:  Jitka Novotna; Bertolt Gust; Andreas Kulik; Jaroslav Spizek; Lutz Heide
Journal:  J Ind Microbiol Biotechnol       Date:  2013-05-08       Impact factor: 3.346

10.  Biological activities of novel gyrase inhibitors of the aminocoumarin class.

Authors:  Christine Anderle; Martin Stieger; Matthew Burrell; Stefan Reinelt; Anthony Maxwell; Malcolm Page; Lutz Heide
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.